Patient who have at 45 years colon cancer and have FAP so what I should or what guidelines do for his children

Reading File
Finding Sources
Searching PubMed

"familial adenomatous polyposis" AND screening

Searching the Web

2024 guidelines familial adenomatous polyposis children genetic testing surveillance APC

For the children, this should be treated as a hereditary cancer syndrome family.

What to do now

  1. Refer the parent and family to a genetic counselor / hereditary colorectal cancer clinic.
    • Confirm the exact genetic result in the parent, usually a disease-causing variant in the APC gene.
    • If the parent has FAP, each child has a 50% chance of inheriting the APC variant because FAP is autosomal dominant.
  2. Test the children for the specific APC variant found in the parent.
    • Predictive testing is usually offered in childhood because the result changes medical screening during childhood.
    • Testing should be done with genetic counseling, including discussion with parents and, when age-appropriate, the child.
  3. If a child tests positive for the familial APC variant:
    • Begin colon surveillance with a pediatric gastroenterologist, typically colonoscopy starting at age 10-15 years, then repeated about every 1-2 years. The exact interval is adjusted for polyp number and findings.
    • If many adenomas develop or they cannot be safely controlled endoscopically, the specialist will discuss preventive colorectal surgery at the appropriate time.
    • Later, they also need surveillance for upper gastrointestinal polyps, commonly with upper endoscopy beginning in early adulthood, as directed by the FAP team.
  4. If a child tests negative for the known familial APC variant:
    • They generally do not need FAP-specific colonoscopic surveillance and can follow routine population colorectal screening advice when they become adults.
  5. If genetic testing is unavailable, declined, or no familial APC variant is identified despite clinical FAP:
    • Treat each child as at risk and start high-quality colonoscopy between ages 10 and 15 rather than waiting for symptoms.
The parent's colon cancer at 45 reinforces the need for timely family evaluation, but the key determinant for the children is whether they carry the family’s APC mutation. Do not wait until age 45 to begin screening in at-risk children.
Current recommendations are summarized in the NCI hereditary colorectal cancer guidance, which states that at-risk minors not tested should start colonoscopy at ages 10-15. The 2024 European FAP guideline also supports structured genetic testing and surveillance pathways (PMID 38722804).

What surveillance schedule is recommended for APC-positive children?

Reading File
Finding Sources
Searching PubMed

"familial adenomatous polyposis" AND surveillance

Searching the Web

APC-associated polyposis conditions GeneReviews surveillance children colonoscopy hepatoblastoma thyroid ultrasound

Reading Web Page

https://www.ncbi.nlm.nih.gov/books/NBK1345

Reading Article

PMID: 38722804

Finding Sources
For a child with a confirmed pathogenic APC variant causing classic FAP, surveillance is generally:
Age / stageRecommended surveillance
At diagnosis / by age 10-12Care in a hereditary polyposis clinic, with pediatric gastroenterology, colorectal surgery, and genetics input.
Age 10-15 onwardFull colonoscopy every 1-2 years. Remove polyps that can be safely removed. Earlier colonoscopy is appropriate if bleeding, anemia, bowel symptoms, or a family pattern of very early/severe disease occurs.
If polyps become numerous or advancedShorten endoscopic intervals as advised by the specialist and discuss timing/type of prophylactic colorectal surgery. Surgery is considered for cancer, severe symptoms, high-grade dysplasia, rapidly increasing burden, large polyps not controllable endoscopically, or when adequate surveillance is no longer possible.
Age 20-25, or before planned colectomyUpper endoscopy with complete ampullary visualization to look for duodenal and ampullary adenomas. Repeat interval depends on findings and Spigelman stage: roughly every 5 years for low burden, every 3 years for moderate burden, and yearly or more often for advanced disease.
Late adolescence onwardAnnual thyroid clinical examination. Many programs add thyroid ultrasound every 2-5 years, or sooner for a nodule, symptoms, or concerning family history.
From diagnosisAnnual neurologic review and abdominal examination, with imaging directed by symptoms or concern for desmoid tumor. Routine imaging solely for desmoids is not usually done in an asymptomatic child.

Hepatoblastoma screening in young APC-positive children

This is the main area where practices differ. Some North American hereditary-cancer programs consider liver examination, abdominal ultrasound, and serum AFP every 3-6 months from birth through age 5 years, because of the small increased hepatoblastoma risk. Other guidelines do not recommend routine screening for all children because evidence that it improves outcomes is limited. Discuss this specifically with the child’s pediatric cancer-genetics team.
For attenuated FAP, colorectal surveillance usually starts later, in late adolescence, rather than at ages 10-15.
The most important action is colonoscopy every 1-2 years from age 10-15 for classic FAP, with management individualized according to the actual polyp burden. This schedule is outlined in GeneReviews APC surveillance and should be coordinated through a specialized polyposis center. The updated European FAP guideline also recommends specialist-center management (2024 guideline).

Find the latest guidelines for APC-associated FAP surveillance

Reading File
Reading File
Searching PubMed

"familial adenomatous polyposis" AND guideline

Searching the Web

2025 2026 APC-associated familial adenomatous polyposis surveillance guideline NCCN ESGE EHTG ESCP

Searching the Web

APC-associated polyposis conditions surveillance GeneReviews last update 2025 colonoscopy thyroid hepatoblastoma

Finding Sources
Reading Article

PMID: 42683623

Reading Article

PMID: 37682806

Reading Web Page

https://pmc.ncbi.nlm.nih.gov/articles/PMC11081080/

Reading Web Page

https://pmc.ncbi.nlm.nih.gov/articles/PMC11081080/

Finding Sources
For the children, this should be treated as a hereditary cancer syndrome family.

What to do now

  1. Refer the parent and family to a genetic counselor / hereditary colorectal cancer clinic.
    • Confirm the exact genetic result in the parent, usually a disease-causing variant in the APC gene.
    • If the parent has FAP, each child has a 50% chance of inheriting the APC variant because FAP is autosomal dominant.
  2. Test the children for the specific APC variant found in the parent.
    • Predictive testing is usually offered in childhood because the result changes medical screening during childhood.
    • Testing should be done with genetic counseling, including discussion with parents and, when age-appropriate, the child.
  3. If a child tests positive for the familial APC variant:
    • Begin colon surveillance with a pediatric gastroenterologist, typically colonoscopy starting at age 10-15 years, then repeated about every 1-2 years. The exact interval is adjusted for polyp number and findings.
    • If many adenomas develop or they cannot be safely controlled endoscopically, the specialist will discuss preventive colorectal surgery at the appropriate time.
    • Later, they also need surveillance for upper gastrointestinal polyps, commonly with upper endoscopy beginning in early adulthood, as directed by the FAP team.
  4. If a child tests negative for the known familial APC variant:
    • They generally do not need FAP-specific colonoscopic surveillance and can follow routine population colorectal screening advice when they become adults.
  5. If genetic testing is unavailable, declined, or no familial APC variant is identified despite clinical FAP:
    • Treat each child as at risk and start high-quality colonoscopy between ages 10 and 15 rather than waiting for symptoms.
The parent's colon cancer at 45 reinforces the need for timely family evaluation, but the key determinant for the children is whether they carry the family’s APC mutation. Do not wait until age 45 to begin screening in at-risk children.
Current recommendations are summarized in the NCI hereditary colorectal cancer guidance, which states that at-risk minors not tested should start colonoscopy at ages 10-15. The 2024 European FAP guideline also supports structured genetic testing and surveillance pathways (PMID 38722804).For a child with a confirmed pathogenic APC variant causing classic FAP, surveillance is generally:
Age / stageRecommended surveillance
At diagnosis / by age 10-12Care in a hereditary polyposis clinic, with pediatric gastroenterology, colorectal surgery, and genetics input.
Age 10-15 onwardFull colonoscopy every 1-2 years. Remove polyps that can be safely removed. Earlier colonoscopy is appropriate if bleeding, anemia, bowel symptoms, or a family pattern of very early/severe disease occurs.
If polyps become numerous or advancedShorten endoscopic intervals as advised by the specialist and discuss timing/type of prophylactic colorectal surgery. Surgery is considered for cancer, severe symptoms, high-grade dysplasia, rapidly increasing burden, large polyps not controllable endoscopically, or when adequate surveillance is no longer possible.
Age 20-25, or before planned colectomyUpper endoscopy with complete ampullary visualization to look for duodenal and ampullary adenomas. Repeat interval depends on findings and Spigelman stage: roughly every 5 years for low burden, every 3 years for moderate burden, and yearly or more often for advanced disease.
Late adolescence onwardAnnual thyroid clinical examination. Many programs add thyroid ultrasound every 2-5 years, or sooner for a nodule, symptoms, or concerning family history.
From diagnosisAnnual neurologic review and abdominal examination, with imaging directed by symptoms or concern for desmoid tumor. Routine imaging solely for desmoids is not usually done in an asymptomatic child.

Hepatoblastoma screening in young APC-positive children

This is the main area where practices differ. Some North American hereditary-cancer programs consider liver examination, abdominal ultrasound, and serum AFP every 3-6 months from birth through age 5 years, because of the small increased hepatoblastoma risk. Other guidelines do not recommend routine screening for all children because evidence that it improves outcomes is limited. Discuss this specifically with the child’s pediatric cancer-genetics team.
For attenuated FAP, colorectal surveillance usually starts later, in late adolescence, rather than at ages 10-15.
The most important action is colonoscopy every 1-2 years from age 10-15 for classic FAP, with management individualized according to the actual polyp burden. This schedule is outlined in GeneReviews APC surveillance and should be coordinated through a specialized polyposis center. The updated European FAP guideline also recommends specialist-center management (2024 guideline).

Quick answer

The most current major guideline specifically addressing APC-associated FAP is:
  1. ACG Clinical Guideline: Diagnosis and Management of Adenomatous Colorectal Polyposis Syndromes, 2026
    Mankaney et al., American Journal of Gastroenterology. This is the newest North American society guideline found and covers genetic testing, colon and upper-GI surveillance, surgery, extracolonic manifestations, and chemoprevention. PMID 42683623
Other key current guidance:
  1. EHTG-ESCP Updated European Guidelines, 2024
    Broad multidisciplinary FAP, attenuated FAP, MAP, and GAPPS management guideline. Note that an erratum was published, so use the corrected version. PMID 38722804
  2. ASCRS Clinical Practice Guideline, 2024
    Particularly useful for indications and choice of colorectal surgery, plus post-surgical surveillance. PMID 37682806
  3. NCCN Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric, version 1.2025
    Current NCCN framework for FAP/APC testing and clinical management. Registration may be required. NCCN guideline page
  4. GeneReviews: APC-Associated Polyposis Conditions
    A practical, frequently updated surveillance summary, though it is a reference resource rather than a society guideline. APC surveillance table

Practical surveillance schedule for classic APC-positive FAP

Until the treating polyposis clinic applies the full 2026 ACG guideline to the individual:
  • Colonoscopy: begin age 10-15 years, repeat every 1-2 years. Shorten interval if adenomas are numerous, rapidly increasing, large, advanced histology is found, or colon clearance becomes difficult.
  • Colectomy discussion: if cancer is suspected or present, there are symptoms, high-grade dysplasia, increasing or unmanageable adenoma burden, large unresectable adenomas, or surveillance is not feasible.
  • Upper GI surveillance: EGD with careful ampullary visualization by age 20-25 years, or before colectomy. Follow-up is based on duodenal/ampullary burden and Spigelman stage, ranging approximately from 6 months to 5 years.
  • Thyroid: current European guidance suggests that if thyroid surveillance is used, include physical examination and ultrasound. It may start around age 16 in females and adulthood in males; if baseline ultrasound is normal, repeat approximately every 2-3 years.
  • Hepatoblastoma: some programs consider liver examination, abdominal ultrasound, and serum AFP every 3-6 months from birth through age 5 years. This is less uniformly recommended because evidence of benefit is limited.
  • Desmoids/CNS: clinical neurologic and abdominal assessment, with imaging driven by symptoms, examination, family history, surgery planning, or concern for desmoid disease.
The child should be managed through a specialized hereditary polyposis clinic, since surveillance and surgery timing are tailored to the family’s APC variant, phenotype, polyp burden, and ability to maintain high-quality colonoscopy.

Find the latest pediatric FAP surveillance recommendations

Reading File
Searching PubMed

"familial adenomatous polyposis" AND pediatric AND surveillance

Searching the Web

2026 pediatric FAP surveillance recommendations APC colonoscopy hepatoblastoma thyroid guideline

Finding Sources
Searching PubMed

"familial adenomatous polyposis" AND hepatoblastoma

Reading Web Page

https://pmc.ncbi.nlm.nih.gov/articles/PMC12826535

Reading Article

PMID: 42683623

Reading Article

PMID: 38722804

Latest pediatric FAP surveillance recommendations

The newest pediatric-focused source found is the AACR Childhood Cancer Predisposition Working Group update, Pediatric cancer screening in hereditary gastrointestinal cancer risk syndromes (2026). It updates earlier 2017 pediatric recommendations and is more specific for children than adult FAP guidelines. The newest overall North American FAP guideline is the ACG 2026 guideline (PMID 42683623); it should be used alongside pediatric expertise.

For a child with a confirmed pathogenic APC variant causing classic FAP

AreaCurrent pediatric recommendation
Genetic counseling/testingTest for the known familial APC variant. Testing by around age 10 years is typical because colonoscopy begins then. Consider testing in infancy if the family chooses hepatoblastoma surveillance.
Colorectal surveillanceColonoscopy from age 10-15 years, every year in the AACR pediatric update. Start sooner if rectal bleeding, anemia, bowel symptoms, or unusually early/severe FAP in the family. Remove polyps when feasible.
Upper GI tractEGD with careful duodenal/ampullary assessment from age 20-25 years. Earlier only when clinically indicated or around colectomy planning. Subsequent interval should be based on gastric, duodenal, and ampullary adenoma burden, usually using Spigelman staging.
Thyroid cancerThyroid ultrasound beginning at age 16 years, every 2 years in the AACR pediatric update. This differs somewhat from older guidance that allowed examination with or without ultrasound. Refer thyroid nodules to pediatric endocrinology and use ultrasound-guided FNA when indicated.
HepatoblastomaAbdominal/liver ultrasound plus serum AFP every 3 months from infancy until age 7 years in the AACR update. This is a strengthened recommendation compared with older guidance.
Medulloblastoma/CNSAnnual clinical neurologic examination through childhood, with prompt assessment and brain imaging for concerning neurologic symptoms. Routine brain MRI in an asymptomatic child is not generally recommended.
Desmoid tumorsClinical abdominal examination. Routine abdominal MRI is not needed in every child, but the AACR update recommends MRI abdomen/pelvis in those at higher desmoid risk, particularly after colectomy or with a strong family history/high-risk APC genotype.
After surgeryOngoing endoscopy is lifelong. The retained rectum after ileorectal anastomosis, ileal pouch after IPAA, or ileostomy must be scoped at intervals set by polyp burden, commonly every 1-2 years.

Surgery

Colectomy is not performed simply because a child has an APC variant. Timing is individualized by a pediatric FAP multidisciplinary team. It is considered when there is colorectal cancer or strong suspicion of cancer, substantial bleeding or symptoms, high-grade dysplasia, rapidly increasing adenoma burden, large adenomas not manageable endoscopically, or inability to perform reliable surveillance.

Important differences between current sources

  • The pediatric AACR update supports annual colonoscopy after surveillance begins.
  • GeneReviews and some other guideline summaries state every 1-2 years for classic FAP, beginning at age 10-15.
  • For hepatoblastoma, older sources often suggested ultrasound/AFP every 3-6 months until age 5. The newer AACR pediatric update recommends the more intensive every-3-month schedule through age 7.
For attenuated FAP, surveillance often begins later, in late adolescence, and intervals can be adjusted to the phenotype. This schedule is for classic APC-associated FAP.
The key sources are the AACR pediatric surveillance update, the 2026 ACG guideline, and the practical GeneReviews surveillance table. The 2024 European FAP guideline remains useful but has an associated erratum (PMID 38722804).
This is a shared conversation. Sign in to Orris to start your own chat.